Drug Profile
MSC 2015103B
Alternative Names: AS703988; MSC2015103BLatest Information Update: 02 Mar 2021
Price :
$50
*
At a glance
- Originator Merck Serono
- Class Antineoplastics; Small molecules
- Mechanism of Action MAP kinase kinase 1 inhibitors; MAP kinase kinase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Solid tumours